Alerts

Concerns have been expressed that a range of breast screening devices based on technologies other than mammography have not been appropriately assessed for their safety or accuracy.

SuperPowerful Man tablets pose a serious health risk and should not be taken. They contain undeclared sulfosildenafil and tadalafil and have not been assessed for quality, safety or efficacy.

FU YUAN CHUN capsules pose a serious health risk and should not be taken. They contain undeclared tadalafil, which may cause serious adverse health effects.

SATIBO capsules pose a serious health risk and should not be taken. They contain undeclared tadalafil and hydroxyhomosildenafil. Both may be harmful if taken without medical supervision.

During the 2010 influenza season an excess number of cases of febrile reactions and febrile convulsions were observed in paediatric populations following immunisation with one of the registered seasonal trivalent influenza vaccines.

SATURO capsules pose a serious health risk and should not be taken. They contain undeclared sildenafil. This may be harmful if taken without medical supervision.

On 26 January 2011, the US Food and Drug Administration (FDA) announced a safety communication to warn about an association between breast implants and anaplastic large cell lymphoma. The risk of a patient developing this type of lymphoma is very low.

There have been some instances in Europe where the controller on the subject units has spontaneously ignited due to a faulty controller setting.

Minicrosser-Cyclone DX, 3- and 4-wheel mobility scooters, Models 130T & 140T, manufactured before January 2007, are being recalled.

The combination of products may not be suitable for use as a vehicle transport device.

Otto Bock Australia Pty Ltd has initiated a recall of a number of mobility chairs consisting of the combination of the Otto Bock Discovery Wheelbase and the Leckey Mygo Seat.

Abbott Diabetes Care has identified a problem associated with the slow filling with certain lots of Optium blood glucose test strips.

Slimming Factor weight loss capsules pose a serious health risk and should not be taken. The contain undeclared sibutramine, fenfluramine and phenolphthalein. All substances have serious safety concerns.

Updated advisory.

We are recalling Thelin (sitaxentan) worldwide due to serious liver risks. Consult your doctor if you have concerns.

Seasonal flu vaccine: Response to the West Australian (Stokes) Review

Some cartons of Perindopril 2mg tablets labelled with batch numbers 24967, 24979, 25180, 25184 may contain Perindopril 8mg tablets

2010 recall of APO-Perindopril 2mg tablets.

We have notified Johnson & Johnson Pacific that we are undertaking a consumer level recall of selected lots of 1-Day Acuvue TruEye contact lenses, as a precautionary measure.

Sponsor dispatched recall letters to all affected optometrists

So Hard for Men tablets, Shaguar tablets and Pulse8 for Women capsules pose a serious risk to your health and should not be taken. They contain undeclared tadalafil and have not been assessed for quality, safety or efficacy.

Weight loss drug Sibutramine (Reductil) withdrawn in Australia due to heart risks.

About Brachytherapy kits (regulatory status).

The national immunisation program with Panvax® began on 30 September 2009. The TGA has been closely monitoring any side effects from the use of the vaccine.

The Therapeutic Goods Administration (TGA) has received enquiries about the recall of the LCS® DuofixTM Femoral Knee Replacement Component.